DailyMed - POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 CREMA- octinoxate powder POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 FLAN- octinoxate powder POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 ALFAJOR- octinoxate powder POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 WAFFLE- octinoxate powder POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 COCADA- octinoxate powder POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 CAPUCCINO- octinoxate powder POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 MANJAR- octinoxate powder POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 MOCHA- octinoxate powder POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 COCOA- octinoxate powder

NDC Code(s): 14141-854-01, 14141-855-01, 14141-856-01, 14141-857-01, view more
14141-858-01, 14141-859-01, 14141-860-01, 14141-861-01, 14141-862-01
Packager: BEL STAR S A

Category: HUMAN OTC DRUG LABEL
DEA Schedule: None

Drug Label Information

Updated December 18, 2023

If you are a consumer or patient please visit this version.

Download DRUG LABEL INFO: PDF XML
Official Label (Printer Friendly)

View All Sections

ACTIVE INGREDIENT

Active Ingredients Purpose

Octinoxate 5.0% Sunscreen
PURPOSE

Uses

Helps Prevent Sunburn
KEEP OUT OF REACH OF CHILDREN

Keep out reach of children.If swallowed get medical help or contact a Poison Control Center right away.
INDICATIONS & USAGE

Stop use and ask a doctor ifrash occurs.
WARNINGS

Warnings

Skin Cancer/Skin Aging Alert:Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn notskin cancer or early skin aging.

Do not useon damaged or broken skin
When using this productkeep out of eyes. Rinse with water to remove
For external use only
DOSAGE & ADMINISTRATION

Directions

Apply generously and evenly 15 minutes before sun exposure

Reapply at least every 2 hours.

Use a water-resistant sunscreen if swimming or sweating
Children under 6 months of age: ask a doctor.
OTHER SAFETY INFORMATION
Other information
- Protect the product in this container from excessive heat and direct sun
INACTIVE INGREDIENT

Inactive ingredients:mica, talc, zinc stearate, methyl methacrylate crosspolymer, boron nitride, dimethicone, octyldodecanol, trimethylsiloxysilicate, perfluorooctyl triethoxysilane, tocopheryl acetate, magnesium myristate, phenoxyethanol, caprylyl glycol, fragrance, chlorphenesin, benzyl alcohol, linalool, hexyl cinnamal, limonene. May Contain:titanium dioxide, iron oxides.
PRINCIPAL DISPLAY PANEL

Cyzone

Studio Look

Polvos Compactos de alta cobertura con FPS 20 Crema

Net wt. 0.24 oz 7g
PRINCIPAL DISPLAY PANEL

Cyzone

Studio Look

Polvos Compactos de alta cobertura con FPS 20 Flan

Net wt. 0.24 oz 7g
PRINCIPAL DISPLAY PANEL

Cyzone

Studio Look

Polvos Compactos de alta cobertura con FPS 20 Alfajor

Net wt. 0.24 oz 7g
PRINCIPAL DISPLAY PANEL

Cyzone

Studio Look

Polvos Compactos de alta cobertura con FPS 20 Waffle

Net wt. 0.24 oz 7g
PRINCIPAL DISPLAY PANEL

Cyzone

Studio Look

Polvos Compactos de alta cobertura con FPS 20 Cocada

Net wt. 0.24 oz 7g
PRINCIPAL DISPLAY PANEL

Cyzone

Studio Look

Polvos Compactos de alta cobertura con FPS 20 Capuccino

Net wt. 0.24 oz 7g
PRINCIPAL DISPLAY PANEL

Cyzone

Studio Look

Polvos Compactos de alta cobertura con FPS 20 Manjar

Net wt. 0.24 oz 7g
PRINCIPAL DISPLAY PANEL

Cyzone

Studio Look

Polvos Compactos de alta cobertura con FPS 20 Mocha

Net wt. 0.24 oz 7g
PRINCIPAL DISPLAY PANEL

Cyzone

Studio Look

Polvos Compactos de alta cobertura con FPS 20 Cocoa

Net wt. 0.24 oz 7g

INGREDIENTS AND APPEARANCE

POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 CREMA
octinoxate powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:14141-854
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	5 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
LINALOOL, (+/-)- (UNII: D81QY6I88E)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
FERRIC OXIDE RED (UNII: 1K09F3G675)
CHLORPHENESIN (UNII: I670DAL4SZ)
BENZYL ALCOHOL (UNII: LKG8494WBH)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
.ALPHA.-HEXYLCINNAMALDEHYDE (UNII: 7X6O37OK2I)
METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER (UNII: EG97988M5Q)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
DIMETHICONE (UNII: 92RU3N3Y1O)
TRIMETHYLSILOXYSILICATE (M/Q 1.0-1.2) (UNII: 78GX033D7I)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
TALC (UNII: 7SEV7J4R1U)
ZINC STEARATE (UNII: H92E6QA4FV)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)
MAGNESIUM MYRISTATE (UNII: Z1917F0578)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
OCTYLDODECANOL (UNII: 461N1O614Y)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:14141-854-01	7 g in 1 CARTON; Type 0: Not a Combination Product	04/01/2020

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M020	04/01/2020	02/09/2025

POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 FLAN
octinoxate powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:14141-855
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	5 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
LINALOOL, (+/-)- (UNII: D81QY6I88E)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
FERRIC OXIDE RED (UNII: 1K09F3G675)
BENZYL ALCOHOL (UNII: LKG8494WBH)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
.ALPHA.-HEXYLCINNAMALDEHYDE (UNII: 7X6O37OK2I)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
TRIMETHYLSILOXYSILICATE (M/Q 1.0-1.2) (UNII: 78GX033D7I)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER (UNII: EG97988M5Q)
DIMETHICONE (UNII: 92RU3N3Y1O)
TALC (UNII: 7SEV7J4R1U)
ZINC STEARATE (UNII: H92E6QA4FV)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)
MAGNESIUM MYRISTATE (UNII: Z1917F0578)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
OCTYLDODECANOL (UNII: 461N1O614Y)
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
CHLORPHENESIN (UNII: I670DAL4SZ)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:14141-855-01	7 g in 1 CARTON; Type 0: Not a Combination Product	04/01/2020

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M020	04/01/2020	02/08/2025

POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 ALFAJOR
octinoxate powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:14141-856
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	5 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
LINALOOL, (+/-)- (UNII: D81QY6I88E)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
FERRIC OXIDE RED (UNII: 1K09F3G675)
BENZYL ALCOHOL (UNII: LKG8494WBH)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
.ALPHA.-HEXYLCINNAMALDEHYDE (UNII: 7X6O37OK2I)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
TRIMETHYLSILOXYSILICATE (M/Q 1.0-1.2) (UNII: 78GX033D7I)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER (UNII: EG97988M5Q)
DIMETHICONE (UNII: 92RU3N3Y1O)
TALC (UNII: 7SEV7J4R1U)
ZINC STEARATE (UNII: H92E6QA4FV)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)
MAGNESIUM MYRISTATE (UNII: Z1917F0578)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
OCTYLDODECANOL (UNII: 461N1O614Y)
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
CHLORPHENESIN (UNII: I670DAL4SZ)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:14141-856-01	7 g in 1 CARTON; Type 0: Not a Combination Product	04/01/2020

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M020	04/01/2020	07/16/2024

POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 WAFFLE
octinoxate powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:14141-857
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	5 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
LINALOOL, (+/-)- (UNII: D81QY6I88E)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
FERRIC OXIDE RED (UNII: 1K09F3G675)
BENZYL ALCOHOL (UNII: LKG8494WBH)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
.ALPHA.-HEXYLCINNAMALDEHYDE (UNII: 7X6O37OK2I)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
TRIMETHYLSILOXYSILICATE (M/Q 1.0-1.2) (UNII: 78GX033D7I)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER (UNII: EG97988M5Q)
DIMETHICONE (UNII: 92RU3N3Y1O)
TALC (UNII: 7SEV7J4R1U)
ZINC STEARATE (UNII: H92E6QA4FV)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)
MAGNESIUM MYRISTATE (UNII: Z1917F0578)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
OCTYLDODECANOL (UNII: 461N1O614Y)
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
CHLORPHENESIN (UNII: I670DAL4SZ)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:14141-857-01	7 g in 1 CARTON; Type 0: Not a Combination Product	04/01/2020

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M020	04/01/2020	09/22/2024

POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 COCADA
octinoxate powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:14141-858
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	5 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
LINALOOL, (+/-)- (UNII: D81QY6I88E)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
FERRIC OXIDE RED (UNII: 1K09F3G675)
BENZYL ALCOHOL (UNII: LKG8494WBH)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
.ALPHA.-HEXYLCINNAMALDEHYDE (UNII: 7X6O37OK2I)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
TRIMETHYLSILOXYSILICATE (M/Q 1.0-1.2) (UNII: 78GX033D7I)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER (UNII: EG97988M5Q)
DIMETHICONE (UNII: 92RU3N3Y1O)
TALC (UNII: 7SEV7J4R1U)
ZINC STEARATE (UNII: H92E6QA4FV)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)
MAGNESIUM MYRISTATE (UNII: Z1917F0578)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
OCTYLDODECANOL (UNII: 461N1O614Y)
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
CHLORPHENESIN (UNII: I670DAL4SZ)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:14141-858-01	7 g in 1 CARTON; Type 0: Not a Combination Product	04/01/2020

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M020	04/01/2020	09/20/2024

POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 CAPUCCINO
octinoxate powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:14141-859
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	5 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
LINALOOL, (+/-)- (UNII: D81QY6I88E)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
FERRIC OXIDE RED (UNII: 1K09F3G675)
BENZYL ALCOHOL (UNII: LKG8494WBH)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
.ALPHA.-HEXYLCINNAMALDEHYDE (UNII: 7X6O37OK2I)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
TRIMETHYLSILOXYSILICATE (M/Q 1.0-1.2) (UNII: 78GX033D7I)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER (UNII: EG97988M5Q)
DIMETHICONE (UNII: 92RU3N3Y1O)
TALC (UNII: 7SEV7J4R1U)
ZINC STEARATE (UNII: H92E6QA4FV)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)
MAGNESIUM MYRISTATE (UNII: Z1917F0578)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
OCTYLDODECANOL (UNII: 461N1O614Y)
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
CHLORPHENESIN (UNII: I670DAL4SZ)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:14141-859-01	7 g in 1 CARTON; Type 0: Not a Combination Product	04/01/2020

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M020	04/01/2020	06/14/2025

POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 MANJAR
octinoxate powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:14141-860
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	5 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
LINALOOL, (+/-)- (UNII: D81QY6I88E)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
FERRIC OXIDE RED (UNII: 1K09F3G675)
BENZYL ALCOHOL (UNII: LKG8494WBH)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
.ALPHA.-HEXYLCINNAMALDEHYDE (UNII: 7X6O37OK2I)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
TRIMETHYLSILOXYSILICATE (M/Q 1.0-1.2) (UNII: 78GX033D7I)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER (UNII: EG97988M5Q)
DIMETHICONE (UNII: 92RU3N3Y1O)
TALC (UNII: 7SEV7J4R1U)
ZINC STEARATE (UNII: H92E6QA4FV)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)
MAGNESIUM MYRISTATE (UNII: Z1917F0578)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
OCTYLDODECANOL (UNII: 461N1O614Y)
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
CHLORPHENESIN (UNII: I670DAL4SZ)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:14141-860-01	7 g in 1 CARTON; Type 0: Not a Combination Product	04/01/2020

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M020	04/01/2020	03/15/2025

POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 MOCHA
octinoxate powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:14141-861
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	5 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
LINALOOL, (+/-)- (UNII: D81QY6I88E)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
FERRIC OXIDE RED (UNII: 1K09F3G675)
BENZYL ALCOHOL (UNII: LKG8494WBH)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
.ALPHA.-HEXYLCINNAMALDEHYDE (UNII: 7X6O37OK2I)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
TRIMETHYLSILOXYSILICATE (M/Q 1.0-1.2) (UNII: 78GX033D7I)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER (UNII: EG97988M5Q)
DIMETHICONE (UNII: 92RU3N3Y1O)
TALC (UNII: 7SEV7J4R1U)
ZINC STEARATE (UNII: H92E6QA4FV)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)
MAGNESIUM MYRISTATE (UNII: Z1917F0578)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
OCTYLDODECANOL (UNII: 461N1O614Y)
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
CHLORPHENESIN (UNII: I670DAL4SZ)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:14141-861-01	7 g in 1 CARTON; Type 0: Not a Combination Product	04/01/2020

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M020	04/01/2020	09/20/2024

POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 COCOA
octinoxate powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:14141-862
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	5 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
LINALOOL, (+/-)- (UNII: D81QY6I88E)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
FERRIC OXIDE RED (UNII: 1K09F3G675)
BENZYL ALCOHOL (UNII: LKG8494WBH)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
.ALPHA.-HEXYLCINNAMALDEHYDE (UNII: 7X6O37OK2I)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
TRIMETHYLSILOXYSILICATE (M/Q 1.0-1.2) (UNII: 78GX033D7I)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER (UNII: EG97988M5Q)
DIMETHICONE (UNII: 92RU3N3Y1O)
TALC (UNII: 7SEV7J4R1U)
ZINC STEARATE (UNII: H92E6QA4FV)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)
MAGNESIUM MYRISTATE (UNII: Z1917F0578)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
OCTYLDODECANOL (UNII: 461N1O614Y)
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
CHLORPHENESIN (UNII: I670DAL4SZ)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:14141-862-01	7 g in 1 CARTON; Type 0: Not a Combination Product	04/01/2020

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M020	04/01/2020	09/21/2024

Labeler - BEL STAR S A (880160197)

Name	Address	ID/FEI	Business Operations
Establishment
BEL STAR S A		880160197	manufacture(14141-854, 14141-855, 14141-856, 14141-857, 14141-858, 14141-859, 14141-860, 14141-861, 14141-862)

View All Sections

Published Date (What is this?)	Version	Files
Dec 19, 2023	3 (current)	download
Dec 7, 2020	2	download
May 5, 2020	1	download

View Package Photos

VIEW MORE

Drug Label Info

Safety

Related Resources

More Info For This Drug

Drug Label Information

Find additional resources

Safety

Related Resources

More Info on this Drug

	NDC
1	14141-854-01
2	14141-855-01
3	14141-856-01
4	14141-857-01
5	14141-858-01
6	14141-859-01
7	14141-860-01
8	14141-861-01
9	14141-862-01

View Package Photos

VIEW MORE

Drug Label Info

Safety

Related Resources

More Info For This Drug

Drug Label Information

Find additional resources

Safety

Related Resources

More Info on this Drug

Number of versions: 3

To receive this label RSS feed

To receive all DailyMed Updates for the last seven days

What will I get with the DailyMed RSS feed?

How to discontinue the RSS feed

Why is DailyMed no longer displaying pill images on the Search Results and Drug Info pages?

If this SPL contains inactivated NDCs listed by the FDA initiated compliance action, they will be specified as such.